Related Experiment Video
Updated: May 5, 2026

Quantification of Hypopigmentation Activity In Vitro
Published on: March 6, 2019
Publication trends in vitiligo research from 1991 to 2024: a comprehensive bibliometric analysis
Yuh-Shan Ho1, Hilla Rosenberg2, Jonathan Shapiro3
1CT HO Trend, Taipei City.
None:
Over the last three decades, vitiligo research has expanded across clinical, genetic, and therapeutic domains. Accurate literature retrieval and bibliometric analysis are essential for identifying major themes and emerging topics within this field. A bibliometric analysis was conducted to identify vitiligo-related studies published between 1991 and 2024, using the Science Citation Index Expanded (SCIE) database. Using a "front page" strategy, articles containing "vitiligo" in the title, abstract, or author keywords were included. Extracted data encompassed titles, abstracts, and keywords to identify dominant research themes. Citation indicators, including total and annual citations, were used to assess impact and trends. Analyses were performed using Microsoft Excel 365. A total of 4,925 vitiligo articles were retrieved and divided into three periods: 1991-2010 (1,654); 2011-2018 (1,541); and 2019-2024 (1,730). The most frequent title word was "patients" (17%), while abstracts frequently included "patients" (63%), "skin" (46%), and "treatment" (41%). Prominent author keywords were "melanocytes", "autoimmunity", and a growing focus on "epidemiology". Increasing trends appeared for "immunotherapy" and "oxidative stress", while "efficacy", "prevalence", and "polymorphism" declined. Research is shifting toward molecular mechanisms and innovative therapies, offering guidance for future studies and improved disease understanding and management.
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
iPS Cell Differentiation
